External link, please review our disclaimer.

Organizational Chart Description

2011 NIDA Organizational Structure

Office of the Director

Nora D. Volkow, M.D.
Director

Timothy P. Condon, Ph.D.
Deputy Director

Mary Affeldt, MSM
Associate Director for Management & Operations

Office of Management

Mary Affeldt, MSM
Director

Office of Extramural Affairs

Teresa Levitin, Ph.D.
Director

Office of Science Policy and Communications

Timothy P. Condon, Ph.D.
Director

Division of Clinical Neuroscience and Behavioral Research

Joseph Frascella, Ph.D.
Director

Division of Epidemiology, Services and Prevention Research

Wilson M. Compton, M.D., M.P.E.
Director

Intramural Research Program

Barry J. Hoffer, M.D., Ph.D.
Scientific Director

Center for the Clinical Trials Network

Betty Tai, Ph.D.
Director

Division of Basic Neurosciences and Behavioral Research

David Shurtleff, Ph.D.
Director

Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Phil Skolnick, Ph.D., D.Sc.
Director

Go Back To: Fiscal Year 2011 Budget Information - Congressional Justification for National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site